03.12.15
Jason Moore has been appointed vice president of global program management at Camargo Pharmaceutical Services. Mr. Moore will be responsible for enhancing the company’s project management process from proposals through project completion.
Mr. Moore has more than 20 years of global drug development experience, including expertise in enterprise project management and portfolio optimization, clinical studies and regulatory submissions, and extensive knowledge of the laws, regulations and guidances governing global drug development.
He joins the company from PLx Pharma, where he served as vice president for seven years, and led all regulatory affairs functions and product submissions for five investigational new drugs and one approved new drug application. He also held positions of increasing responsibility at BioHouston, Introgen and Agenus.
Ken Phelps, Camargo’s president and chief executive officer, said, “Camargo has achieved significant growth over the past few years, and leaders like Jason are both the sustainers and drivers of that growth and the reason we’ll be able to build on it in the future.”
Mr. Moore has more than 20 years of global drug development experience, including expertise in enterprise project management and portfolio optimization, clinical studies and regulatory submissions, and extensive knowledge of the laws, regulations and guidances governing global drug development.
He joins the company from PLx Pharma, where he served as vice president for seven years, and led all regulatory affairs functions and product submissions for five investigational new drugs and one approved new drug application. He also held positions of increasing responsibility at BioHouston, Introgen and Agenus.
Ken Phelps, Camargo’s president and chief executive officer, said, “Camargo has achieved significant growth over the past few years, and leaders like Jason are both the sustainers and drivers of that growth and the reason we’ll be able to build on it in the future.”